-
Awarded29/11/2024
-
Today15/07/2025
Utilities
- indicates text translated automatically in your browsing language
Supplies of the radiopharmaceutical fluordopa – (18F) Text automatically translated in your browsing language Automatically translated
The subject of the contract is to ensure the recurring supply of the medicinal product fluordopa – (18F) to the PET Centre building, Nuclear Medicine Department, for a period of 24 months from the date of entry into force of the framework agreement between the contracting authority and the contractor. Text automatically translated in your browsing language Automatically translated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.